Browse studies

Find your next paid study

27,250 recruiting studies available now

Pharmacokinetics of Drugs Administered to Children Per Standard of Care

This is a prospective study of children \<21 years of age with the goal of characterizing the PK of drugs administered per standard of care as prescribed by th…

Pediatric ALL

Estimated

~$10 – $750

Duke UniversityNCT03481881

Phase 2

A Phase II Study Evaluating the Safety and Efficacy of the Combination of Zanubrutinib Plus Lisocabtagene Maraleucel for Richter's Syndrome

This phase II trial tests how well zanubrutinib and lisocabtagene maraleucel (liso-cel) work together in treating patients with Richter's syndrome that has com…

Recurrent Transformed Chronic Lymphocytic LeukemiaRefractory Transformed Chronic Lymphocytic LeukemiaTransformed Chronic Lymphocytic Leukemia to Diffuse Large B-Cell Lymphoma+5 more

Estimated

~$10 – $7,500

Aseel AlsouqiNCT05873712

Phase 3

Erector Spinae Versus Intercostal Nerve Blocks With Liposomal Bupivacaine for Analgesia in Thoracic Surgery

This clinical trial compares efficacy in postoperative pain management in thoracic surgery between erector spinae block versus liposomal bupivacaine injections.

Lung Cancers

Estimated

~$10 – $6,250

George Washington UniversityNCT06810375

Observational

URIPRENE: Clinical Study to Evaluate the Safety and Device Performance of the ADVA-Tec Uriprene® Degradable Temporary Ureteral Stent Following Uncomplicated Ureteroscopy

A prospective, multi-center, non-randomized trial to demonstrate safety and device performance of the ADVA-Tec Uriprene® Degradable Temporary Ureteral Stent.

Leveraging Semaglutide for Preservation of Beta Cell Function and Restoration of Alpha Cell Function

This study seeks to evaluate the hormone responses of insulin, c-peptide, glucagon, and incretins to semaglutide, a GLP-1 receptor agonist therapy, in individu…

Stage 1 Diabetes Mellitus, Type 1

Estimated

~$10 – $5,625

Children's Hospital Medical Center, CincinnatiNCT07430332

Phase 1

A Phase 1, Open-Label, Single Center Study of KYV-101, an Autologous Fully-Human Anti-CD19 Chimeric Antigen Receptor T-Cell (CD19 CAR T) Therapy in Subjects With Non-relapsing and Progressive Forms of Multiple Sclerosis

A Study of Anti-CD19 Chimeric Antigen Receptor T Cell Therapy in Subjects with Non-relapsing and Progressive Forms of Multiple Sclerosis

Multiple SclerosisMultiple Sclerosis, Primary ProgressiveMultiple Sclerosis, Secondary Progressive

Estimated

~$10 – $6,250

Stanford UniversityNCT06138132

The Use of Leukapheresis to Support HIV Pathogenesis Studies

Despite the dramatic improvements that have resulted from combination antiretroviral treatment, long-term efficacy, toxicity, cost, and the requirements for li…

HIV

Estimated

~$10 – $675

University of California, San FranciscoNCT01161199

Observational

Prospective Randomized Sibling-Oocyte Trial Comparing Fertilization and Embryo Development Outcomes Between Intracytoplasmic Sperm Injection (ICSI) and Conventional IVF Using Frozen Donor Sperm

The goal of this clinical trial is to learn whether two different methods of helping eggs and sperm join-intracytoplasmic sperm injection (ICSI) and convention…

Infertility, FemaleReproductive Techniques, AssistedFertilization in Vitro

Estimated

~$10 – $7,500

Shady Grove Fertility Reproductive Science CenterNCT07175571

Phase 3

Outcomes of High-risk Non-muscle Invasive Bladder Cancer Treated With Blue Light Resection

Comparing white-light cystoscopy (WLC) and blue-light cystoscopy (BLC) in TURBT for high risk (HR) non-muscle invasive bladder cancer (NMIBC) patients is cruci…

Bladder Cancer

Estimated

~$10 – $6,250

Johns Hopkins UniversityNCT06525571

Pituitary Tumor Surveillance: Pathogenetic Correlation

The purpose of this study is to observe predictors of pituitary tumor recurrence and markers of persistent disease activity in patients harboring pituitary mas…

Pituitary Tumor

Estimated

~$10 – $750

Cedars-Sinai Medical CenterNCT00599092

Phase 1

A Phase 1a/b Study to Evaluate the Safety and Efficacy of OPB-101, an Autologous Mesothelin (MSLN) CAR T Cell Therapy With Antigen-dependent Expression of OUTSMART™ Designed IL-2 Cytokine in Platinum-resistant Ovarian Cancer

The goal of this clinical trial is to learn if OPB-101 is safe in platinum resistant ovarian cancer participants and also to find the optimal dose of OPB-101. …

Ovarian Cancer RecurrentOvarian CancerPlatinum Resistant Ovarian Cancer

Estimated

~$10 – $8,750

Outpace Bio, Inc.NCT07030907

Observational

Can EmeraldLED Reshape Your Body With Continued Use?

Already using EmeraldLED? TheGreen Light Therapy study explores how continuing participants' 15-minute sessions, twice a week, may continue to support positive…

Body Composition

Estimated

~$10 – $8,750

Efforia, IncNCT07282119